stockrow
Friday 6 November 2026
Export THC’s income statement to Excel — free account
Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
Tenet Healthcare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $21.3 billion, up 3.07% from fiscal 2024.
- Revenue
- +6.47%
- EPS
- +291.1%
- Free cash flow
- +39.2%
- Total debt
- +0.42%
Quarter to September 2026, against a year earlier
283.11
3.35
−1.17%
Follow THC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
12.73 | 9.73 | 7.16 | 6.83 |
P/S ratio |
0.84 | 0.76 | 0.72 | 0.92 | |
P/FCF ratio |
7.08 | 4.89 | 5.17 | 6.15 | |
P/Operating CF |
24.51 | 9.98 | 26.71 | 15.99 | |
P/B ratio |
2.98 | 2.44 | 2.38 | 2.76 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.32 | 1.24 | 1.22 | 1.40 | |
EV/EBITDA |
6.42 | 5.14 | 4.25 | 4.35 | |
EV/Operating CF |
7.97 | 6.10 | 6.65 | 7.33 | |
EV/FCF |
11.15 | 7.95 | 8.83 | 9.33 | |
Quick Ratio |
1.22 | 0.91 | 0.86 | 0.99 | |
Current Ratio |
1.76 | 1.36 | 1.41 | 1.58 | |
Net Debt/EBITDA |
9.45 | 5.27 | 5.19 | 5.36 | |
Debt/Assets |
44.38% | 42.33% | 43.19% | 41.92% | |
Debt/Equity |
2.19 | 1.97 | 2.02 | 1.79 | |
Asset Turnover |
0.73 | 0.71 | 0.73 | 0.73 | |
Operating CF/Net income |
1.97 | 2.34 | 0.71 | 1.28 | |
Capex/Depreciation |
(1.54) | (0.77) | (0.76) | (0.89) | |
Interest Coverage |
4.16 | 8.34 | 9.38 | 8.62 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.42 | 0.41 | 0.41 | 0.41 | |
Share Based Compensation of Revenue |
0.45% | 0.47% | 0.78% | 0.62% | |
Graham Net Nets |
(0.88) | (0.98) | (1.04) | (0.77) | |
Graham Number |
153.11 | 183.69 | 214.80 | 279.20 | |
Earnings Yield |
7.86% | 10.28% | 13.96% | 14.65% | |
Free Cash Flow Yield |
14.12% | 20.45% | 19.35% | 16.25% | |
Revenue per Share |
61.31 | 61.84 | 67.38 | 70.27 | |
Operating CF per Share |
8.11 | 18.91 | 7.00 | 15.99 | |
Capex per Share |
(4.04) | (2.07) | (2.01) | (2.47) | |
Free Cash Flow per Share |
4.07 | 16.83 | 4.99 | 13.51 | |
Cash per Share |
31.98 | 34.18 | 25.98 | 33.37 | |
Shareholders Equity per Share |
66.74 | 77.34 | 78.50 | 92.53 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
66.74 | 77.34 | 78.50 | 92.53 | |
Free Cash Flow |
367.00 | 1,461.00 | 417.00 | 1,083.00 | |
Working Capital |
3,386.00 | 2,204.00 | 2,260.00 | 3,110.00 | |
Capital Expenditures |
(364.00) | (180.00) | (168.00) | (198.00) | |
Net Current Asset Value |
(15,811.00) | (16,134.00) | (16,292.00) | (15,749.00) | |
EV/EBIT |
8.04 | 6.23 | 4.98 | 4.99 | |
Capex to Sales |
0.07 | 0.03 | 0.03 | 0.04 | |
Price to Operating Income |
5.11 | 3.83 | 2.91 | 3.29 | |
| Other line items | |||||
Average Receivables |
2,550.50 | 2,612.00 | 2,570.50 | 2,556.50 | |
Average Payables |
1,327.00 | 1,333.00 | 1,365.50 | 1,371.50 | |
Average Inventory |
347.00 | 343.50 | 338.00 | 343.00 | |
Average Assets |
29,306.50 | 30,220.00 | 29,687.50 | 30,505.00 | |
Average Common Equity |
5,918.50 | 6,295.00 | 6,016.50 | 6,599.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026